Fig. 2From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional statusMean and standard error (SE) of Haemoglobin (Hb) for IV iron (Ferric Derisomaltose) versus IV placebo at baseline, 1 month and 3 monthsBack to article page